Keyphrases
Covalent Binding
100%
Prostaglandins
100%
Cyclopentenone Prostaglandins
100%
P300
44%
Cell-based
22%
Inhibitory Activity
22%
Electrophilic
22%
Acetylation
22%
Cyclopentenone
22%
Mass Spectrometry Analysis
11%
Recombinant
11%
Site-directed mutagenesis
11%
In Vitro Assay
11%
Neurodegeneration
11%
Histone H3
11%
Filter Binding Assay
11%
Assay System
11%
Prostaglandin D2 (PGD2)
11%
Histone Acetylation
11%
Michael Addition
11%
Substrate Binding Site
11%
Unsaturation
11%
H3 Histone
11%
Histone Acetyltransferase
11%
Domain Peptide
11%
Competition Assay
11%
Biochemistry, Genetics and Molecular Biology
Histone Acetyltransferase
100%
Prostaglandin
100%
Acetylation
22%
Electrophilicity
22%
Mass Spectrometry
11%
Binding Site
11%
Wild Type
11%
Site-Directed Mutagenesis
11%
Human Immunodeficiency Virus 1
11%
Histone H3
11%
Filter Binding Assay
11%
Histone Acetylation
11%
Michael Addition
11%
Docking (Molecular)
11%
Medicine and Dentistry
Prostaglandin
100%
Cyclopentenone
100%
In Vitro
18%
Acetylation
18%
Malignant Neoplasm
9%
Human Immunodeficiency Virus
9%
Binding Site
9%
Neurodegeneration
9%
Mass Spectrum
9%
Histone H3
9%
Histone Acetylation
9%
Site-Directed Mutagenesis
9%
Docking (Molecular)
9%
Binding Assay
9%
Diseases
9%
Chemistry
Prostaglandin
100%
Acetylation
33%
Pharmacology, Toxicology and Pharmaceutical Science
Histone Acetyltransferase
100%
Immunology and Microbiology
Molecular Docking
9%
Michael Addition
9%